CLARITY PHARMACEUTICALS LTD

0.00%

$4.33

Market Cap $1.400B

Healthcare Biotechnology

Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical... Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical company. The Company is focused on developing theranostic (therapy and imaging) products, based on its platform SAR Technology. It is progressing seven clinical trials with its three key products, SARTATE, SAR-bisPSMA, and SAR-Bombesin. SARTATE is developed for diagnosing, staging, and treating cancers that express somatostatin receptor 2 (SSTR2), including neuroblastoma and neuroendocrine tumors (NETs). SAR-bisPSMA is developed for diagnosing, staging, and treating cancers that express Prostate Specific Membrane Antigen (PSMA). SAR-Bombesin is developed for identifying and selecting patients for subsequent treatment of cancers that express a specific receptor called the gastrin releasing peptide receptor (GRPr), including breast cancer and prostate cancer. It has a diverse range of products in clinical trials, which address both large indications as well as rare and orphan indications of cancer.More

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care. LATEST: Race Oncology Accelerates Game-Changing Cancer Drug.

Latest Threads

Tag

Subject

CU6 Biotech

(Potential) short squeeze

30/07/25

103

33K

30/07/25

Last post GreatMinds

103

33K

CU6

Ann: Clarity successfully completes $203 million institutional pl

2 3

30/07/25

139

39K

30/07/25

Last post ma420

139

39K

CU6

CU6 - ASX Charts

52 53 54

30/07/25

3.2K

1.1M

30/07/25

Last post flinstone

3.2K

1.1M

CU6

Ann: Becoming a substantial holder

29/07/25

2.7K

29/07/25

Last post HCmbr

2.7K

CU6

Ann: Co-PSMA trial recruitment successfully completed

29/07/25

18K

29/07/25

Last post Jdmoney

18K

CU6

Price target up 34% to $9.....

29/07/25

5.5K

29/07/25

Last post IronMike94

5.5K

CU6

Ann: Proposed issue of securities - CU6

28/07/25

313

28/07/25

Last post

ASX News

313

CU6

CR tmr

28/07/25

6.5K

28/07/25

Last post at6568

6.5K

See All Discussions

Timeline

Becoming a substantial holder
29 Jul 19:22	Share

Proposed issue of securities - CU6
28 Jul 09:44	Share

Clarity successfully completes $203 million institutional pl
28 Jul 09:42	Share

Change in substantial holding
24 Jul 08:18	Share

Co-PSMA trial recruitment successfully completed
17 Jul 09:45	Share

Notification of cessation of securities - CU6
14 Jul 15:47	Share

Cleansing Notice
04 Jul 10:41	Share

Application for quotation of securities - CU6
04 Jul 10:37	Share

Notice of initial substantial holder
04 Jul 09:12	Share

Change of Director's Interest Notice - M Parker
04 Jul 09:12	Share

Change of Director's Interest Notice - C Biggin
04 Jul 09:08	Share

Change of Director's Interest Notice - A Taylor
04 Jul 09:07	Share

Cleansing Notice
02 Jul 11:51	Share

Application for quotation of securities - CU6
02 Jul 11:48	Share

Change in substantial holding
01 Jul 08:27	Share

Cleansing Notice
24 Jun 09:35	Share

Application for quotation of securities - CU6
24 Jun 09:31	Share

Clarity enters a Commercial Manufacturing Agreement
17 Jun 09:36	Share

SABRE topline results
13 Jun 09:58	Share

DISCO topline results
05 Jun 09:49	Share

Ceasing to be a substantial holder
05 Jun 08:22	Share

Notification regarding unquoted securities - CU6
30 May 11:08	Share

First patient imaged in Phase III AMPLIFY trial
29 May 09:34	Share

AMPLIFY trial commences
20 May 09:55	Share

Ceasing to be a substantial holder
15 May 16:24	Share

Becoming a substantial holder
13 May 15:43	Share

Change in substantial holding
02 May 08:26	Share

Quarterly Activities/Appendix 4C Cash Flow Report
30 Apr 15:06	Share

Change in substantial holding
22 Apr 18:51	Share

Ceasing to be a substantial holder
17 Apr 16:33	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $4.33		Change 0.000(0.00%)		Mkt cap ! $1.400B

Open	High	Low	Value	Volume
$4.31	$4.44	$4.20	$11.74M	2.723M

Buyers (Bids)

No.	Vol.	Price($)
1	5000	$4.31

Sellers (Offers)

Price($)	Vol.	No.
$4.34	132	1

View Market Depth

No.	Vol.	Price($)
1	5000	4.310
2	12150	4.300
3	26354	4.260
1	360	4.250
3	19930	4.240

Price($)	Vol.	No.
4.340	132	1
4.350	22925	2
4.370	3500	1
4.380	5250	2
4.390	15000	3

Last trade - 16.16pm 30/07/2025 (20 minute delay)

CU6 (ASX) Chart

CLARITY PHARMACEUTICALS LTD

Latest Threads

Timeline

Featured News

Latest Videos

Clarity Pharmaceuticals' (ASX:CU6) theranostic prostate cancer trial progresses to highest dose level

10 Aug 2023 12:13 (AEST)

Latest Articles

Clarity scribes deal on delivery of copper 64 isotopes

Clarity Pharmaceuticals Ltd has seen its share price leap after it announced a deal with Nusano to deliver Cu-64 isotopes

Another win for Clarity at FDA as imaging agent fast-tracked for complex prostate cancer

For those unlucky enough to have received a testicular castration to treat prostate cancer, only for it to come back, Clarity Pharmaceuticals’ (ASX:CU6) news on Wednesday morning could offer crucial moral support.For those patients (who have also already received first-stage less ...

Clarity jumps as FDA awards fast track status for PET scan imaging agent

Clarity Pharmaceuticals (ASX:CU6) has seen the U.S. FDA fast-track its prostate cancer imaging compound for use in PET scans on patients with recurring prostate cancer. The stock jumped 4% in the first hour of trade to $4.23 in what is likely a welcome move for shareholders who have already seen ...

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News